Instil Bio, Inc.
TIL
$7.64
$0.060.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.09% | -11.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.27% | -37.03% | |||
| Operating Income | 10.27% | 37.03% | |||
| Income Before Tax | -2.26% | 48.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.26% | 48.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.26% | 48.68% | |||
| EBIT | 10.27% | 37.03% | |||
| EBITDA | 14.22% | 37.08% | |||
| EPS Basic | -2.26% | 48.68% | |||
| Normalized Basic EPS | 14.78% | 41.01% | |||
| EPS Diluted | -2.26% | 48.68% | |||
| Normalized Diluted EPS | 14.78% | 41.01% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||